machine learning

Identifying Research Fronts in the Web of Science: From metrics to meaning

The latest Global Research Report from the Institute for Scientific Information™ (ISI) uses clusters of citations from recently published papers to show the hot and emerging scientific topics that are currently attracting exceptional attention. The ability to find these fronts and to track emerging specialty areas of scientific research, together with the key players at […]

Big data: The future in healthcare is sooner than we think

Data is, of course, driving the future of healthcare. Stakeholders across the industry have been widely preparing for the Big Data transformation and how to put the data to best use. At the recent Financial Times Global Pharmaceutical and Biotechnology Conference titled “Embracing Disruption for a New Era in Health,” several experts examined how to […]

Artificial intelligence: Hype vs. reality and the impact on the patent industry

Introduction The generally accepted definition of artificial intelligence (AI) is the demonstration of intelligence by machines. In computer science AI research is defined as the study of “intelligent agents”: any device that perceives its environment and takes actions that maximize its chance of successfully achieving its goals.  More commonly, it’s a term that is used […]

Patent workflow and technology

The machines are taking over Machine Learning and Artificial Intelligence (AI) are steadily taking over every aspect of routine life including automation in the field of IP. In all aspects of life, the AI revolution is here to help us, even though the solution is removing the human broker from the workflow. Over the last […]

Why is life sciences data integration so hard?

A new analysis and guide from the Life Sciences data integration team at Clarivate Analytics asks the question, “Why is data integration so hard?” The paper looks at the many reasons biopharma companies might want to integrate their vast and often mixed storehouses of data – revisiting an old drug program in light of new […]